Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Siyi Zou

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0762-4110; OpenAlex author ID A5017720925. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Nimotuzumab Plus Gemcitabine-based Adjuvant Chemotherapy for Resectable Pancreatic Cancer: A Retrospective Observational Study. Co-author DOI 10.1097/mpa.0000000000002511↗
  2. Preoperative Score to Stratify Recurrence Risk After Curative Resection of Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Cohort Study First author DOI 10.21203/rs.3.rs-697919/v1↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaxing Deng · 2 shared papers, 2021–2026 · strength 0.44
  2. Qian Zhan · 2 shared papers, 2021–2026 · strength 0.44
  3. Baiyong Shen · 2 shared papers, 2021–2026 · strength 0.44
  4. Lingxi Jiang · 1 shared paper, 2026 · strength 0.29
  5. Chenlei Wen · 1 shared paper, 2026 · strength 0.29
  6. Yu Jiang · 1 shared paper, 2021 · strength 0.15
  7. Weishen Wang · 1 shared paper, 2021 · strength 0.15
  8. Haoda Chen · 1 shared paper, 2021 · strength 0.15

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.